AF
AZN icon

Advisornet Financial’s AstraZeneca AZN Stock Holding History

Advisornet Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19M Sell
11,574
-399
-3% -$75K 0.1% 174
2026
Q1 		$2.36M Buy
11,973
+389
+3% +$75K 0.12% 152
2025
Q4 		$2.13M Buy
11,584
+321
+3% +$56.3K 0.11% 154
2025
Q3 		$1.73M Buy
11,263
+496
+5% +$75.1K 0.1% 182
2025
Q2 		$1.5M Buy
10,767
+12
+0.1% +$1.68K 0.1% 194
2025
Q1 		$1.58M Buy
10,755
+98
+0.9% +$14.2K 0.12% 183
2024
Q4 		$1.4M Sell
10,657
-533
-5% -$74.6K 0.12% 174
2024
Q3 		$1.74M Buy
11,190
+71
+0.6% +$11.5K 0.13% 161
2024
Q2 		$1.73M Buy
11,119
+132
+1% +$19.9K 0.16% 145
2024
Q1 		$1.49M Buy
10,987
+1,060
+11% +$140K 0.14% 155
2023
Q4 		$1.34M Buy
9,927
+1,427
+17% +$186K 0.12% 187
2023
Q3 		$1.15M Buy
8,500
+1,357
+19% +$185K 0.1% 194
2023
Q2 		$1.02M Buy
7,143
+5,389
+307% +$793K 0.09% 209
2023
Q1 		$243K Buy
1,754
+977
+126% +$131K 0.02% 432
2022
Q4 		$105K Buy
777
+295
+61% +$37K 0.01% 613
2022
Q3 		$53K Sell
482
-158
-25% -$20K 0.01% 831
2022
Q2 		$85K Sell
640
-69
-10% -$9.05K 0.01% 716
2022
Q1 		$94K Buy
709
+169
+31% +$20.3K 0.01% 775
2021
Q4 		$63K Buy
540
+46
+9% +$5.41K ﹤0.01% 935
2021
Q3 		$59K Buy
494
+81
+20% +$9.43K ﹤0.01% 952
2021
Q2 		$49K Hold
413
– – ﹤0.01% 987
2021
Q1 		$41K Sell
413
-50
-11% -$5.03K ﹤0.01% 998
2020
Q4 		$46K Sell
463
-6
-1% -$636 ﹤0.01% 890
2020
Q3 		$51K Buy
469
+6
+1% +$667 ﹤0.01% 843
2020
Q2 		$49K Buy
463
+126
+37% +$13K ﹤0.01% 861
2020
Q1 		$30K Sell
337
-43
-11% -$4.05K ﹤0.01% 950
2019
Q4 		$38K Sell
380
-192
-34% -$18.1K ﹤0.01% 981
2019
Q3 		$51K Buy
572
+4
+0.7% +$347 ﹤0.01% 895
2019
Q2 		$47K Sell
568
-213
-27% -$16.7K 0.01% 820
2019
Q1 		$63K Sell
781
-338
-30% -$26.6K 0.01% 671
2018
Q4 		$85K Hold
1,119
– – 0.01% 560
2018
Q3 		$89K Buy
1,119
+108
+11% +$8.17K 0.01% 575
2018
Q2 		$71K Sell
1,011
-5
-0.5% -$360 0.01% 614
2018
Q1 		$71K Hold
1,016
– – 0.01% 609
2017
Q4 		$71K Buy
+1,016
New +$68.5K 0.01% 559

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Advisornet Financial's AZN Position: Q2 2026 in Review

Advisornet Financial reduced its AstraZeneca (AZN) stake by 3.3% in Q2 2026, selling an estimated $75K and leaving 11,574 shares worth $2.19M. The position accounts for 0.1% of the portfolio, ranked #174.

Advisornet Financial first reported a position in AZN in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.36M in Q1 2026. 403 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Advisornet Financial held 11,574 shares of AstraZeneca worth $2.19M as of Q2 2026.
  • Advisornet Financial sold 399 AstraZeneca shares in Q2 2026, an estimated $75K.
  • AstraZeneca made up 0.1% of Advisornet Financial's portfolio in Q2 2026, its #174 holding.
  • Advisornet Financial first reported a position in AstraZeneca in Q4 2017 and has held it in 35 quarters since.
  • Advisornet Financial's AstraZeneca position peaked at $2.36M in Q1 2026.
  • 403 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.